249 related articles for article (PubMed ID: 37461120)
1. Developing and testing a clinical care bundle incorporating caffeine citrate to manage apnoea of prematurity in a resource-constrained setting: a mixed methods clinical feasibility study protocol.
Irimu G; Okwaro F; Coleman J; Waiyego M; Murila F; Chomba D; Parsimei M; Shitote C; Ochieng R; Shah J; Ogero M; Ginsburg AS; Ansermino JM; Macharia W
Implement Sci Commun; 2023 Jul; 4(1):80. PubMed ID: 37461120
[TBL] [Abstract][Full Text] [Related]
2. Sex-based differences in apnoea of prematurity: A retrospective cohort study.
Bairam A; Laflamme N; Drolet C; Piedboeuf B; Shah PS; Kinkead R;
Exp Physiol; 2018 Oct; 103(10):1403-1411. PubMed ID: 29974527
[TBL] [Abstract][Full Text] [Related]
3. Caffeine citrate: a review of its use in apnoea of prematurity.
Comer AM; Perry CM; Figgitt DP
Paediatr Drugs; 2001; 3(1):61-79. PubMed ID: 11220405
[TBL] [Abstract][Full Text] [Related]
4. Caffeine in preterm infants: where are we in 2020?
Moschino L; Zivanovic S; Hartley C; Trevisanuto D; Baraldi E; Roehr CC
ERJ Open Res; 2020 Jan; 6(1):. PubMed ID: 32154294
[TBL] [Abstract][Full Text] [Related]
5. Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants.
He X; Qiu JC; Lu KY; Guo HL; Li L; Jia WW; Ni MM; Liu Y; Xu J; Chen F; Cheng R
Adv Ther; 2021 Jan; 38(1):607-626. PubMed ID: 33180318
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. Specific Premature Groups Have Better Benefits When Treating Apnea With Caffeine Than Aminophylline/Theophylline.
Lin YC; Tan YL; Yen TA; Chen CY; Tsao PN; Chou HC
Front Pediatr; 2022; 10():817624. PubMed ID: 35281246
[TBL] [Abstract][Full Text] [Related]
9. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
Lista G; Fabbri L; Polackova R; Kiechl-Kohlendorfer U; Papagaroufalis K; Saenz P; Ferrari F; Lasagna G; Carnielli VP;
Neonatology; 2016; 109(3):221-7. PubMed ID: 26820884
[TBL] [Abstract][Full Text] [Related]
10. Current options in the management of apnea of prematurity.
Bhatia J
Clin Pediatr (Phila); 2000 Jun; 39(6):327-36. PubMed ID: 10879934
[TBL] [Abstract][Full Text] [Related]
11. A survey of barriers and facilitators to caffeine use for apnoea of prematurity in low- and middle-income countries.
Ginsburg AS; Coleman J; Waiyego M; Murila F; Macharia WM; Ochieng R
Paediatr Int Child Health; 2022; 42(3-4):137-141. PubMed ID: 37462339
[TBL] [Abstract][Full Text] [Related]
12. What do we know about the sleep effects of caffeine used to treat apnoea of prematurity? A systematic review of the literature.
de Toledo ARP; Caetano HA; Skupien JA; Boeck CR; Fiori H; da Silva RS
Mol Cell Pediatr; 2023 Sep; 10(1):13. PubMed ID: 37718322
[TBL] [Abstract][Full Text] [Related]
13. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
14. Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity.
Kumral A; Tuzun F; Yesilirmak DC; Duman N; Ozkan H
Acta Paediatr; 2012 Jul; 101(7):e299-303. PubMed ID: 22462821
[TBL] [Abstract][Full Text] [Related]
15. Caffeine citrate for apnea of prematurity-One dose does not fit all a prospective study.
Rosen C; Taran C; Hanna M; Gueta I; Loebstein R; Strauss T; Yarden-Bilavsky H
J Perinatol; 2021 Sep; 41(9):2292-2297. PubMed ID: 34290376
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of apnoea of prematurity.
Pergolizzi JV; Fort P; Miller TL; LeQuang JA; Raffa RB
J Clin Pharm Ther; 2022 May; 47(5):685-693. PubMed ID: 35018653
[TBL] [Abstract][Full Text] [Related]
17. Discharging Preterm Infants Home on Caffeine, a Single Center Experience.
Ma C; Broadbent D; Levin G; Panda S; Sambalingam D; Garcia N; Ruiz E; Singh AP
Children (Basel); 2020 Aug; 7(9):. PubMed ID: 32872145
[No Abstract] [Full Text] [Related]
18. Caffeine and supplemental oxygen effectively suppress periodic breathing with only minor effects during long episodes of apnoea in preterm infants.
Seppä-Moilanen M; Andersson S; Rantakari K; Mikkola K; Kirjavainen T
Acta Paediatr; 2019 Mar; 108(3):443-451. PubMed ID: 30118174
[TBL] [Abstract][Full Text] [Related]
19. The limited management options for apnoea of prematurity.
Pergolizzi JV; Fort P; Miller TL; LeQuang JA; Raffa RB
J Clin Pharm Ther; 2022 Mar; 47(3):396-401. PubMed ID: 34734423
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
